Heritable pulmonary arterial hypertension

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
A Gastroenterology (ATC A) 1
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
SGLT2 inhibitor 1 substance
Receptor fusion protein 1 substance
Phase II: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial

Phase IV

1 trial
  • Amsterdam UMC Stichting Academic
    SOTATERCEPT
    2024-512543-23-00 1 country 2025 n=20 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Rigshospitalet Academic 1 Phase II 0
Amsterdam UMC Stichting Academic 1 Phase IV 1
New trials by year
2023
1
2025
1
← All indication landscapes